日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antiretroviral drug therapy does not reduce neuroinflammation in an HIV-1 infection brain organoid model

抗逆转录病毒药物疗法并不能减轻 HIV-1 感染脑类器官模型中的神经炎症。

Samuel Martinez-Meza ,Thomas A Premeaux ,Stefano M Cirigliano ,Courtney M Friday ,Stephanie Michael ,Sonia Mediouni ,Susana T Valente ,Lishomwa C Ndhlovu ,Howard A Fine ,Robert L Furler O'Brien # ,Douglas F Nixon #

Economics of Palliative Care for Hospitalized Adults With Serious Illness: A Meta-analysis

住院重症成年患者姑息治疗的经济学:一项荟萃分析

May, Peter; Normand, Charles; Cassel, J Brian; Del Fabbro, Egidio; Fine, Robert L; Menz, Reagan; Morrison, Corey A; Penrod, Joan D; Robinson, Chessie; Morrison, R Sean

Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer

奥拉帕尼联合伊立替康、顺铂和丝裂霉素C治疗晚期胰腺癌

Yarchoan, Mark; Myzak, Melinda C; Johnson, Burles A 3rd; De Jesus-Acosta, Ana; Le, Dung T; Jaffee, Elizabeth M; Azad, Nilofer S; Donehower, Ross C; Zheng, Lei; Oberstein, Paul E; Fine, Robert L; Laheru, Daniel A; Goggins, Michael

Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer

GVAX胰腺初免疫苗和表达间皮素的单核细胞增生李斯特菌(CRS-207)增强疫苗治疗转移性胰腺癌的安全性和生存率

Le, Dung T; Wang-Gillam, Andrea; Picozzi, Vincent; Greten, Tim F; Crocenzi, Todd; Springett, Gregory; Morse, Michael; Zeh, Herbert; Cohen, Deirdre; Fine, Robert L; Onners, Beth; Uram, Jennifer N; Laheru, Daniel A; Lutz, Eric R; Solt, Sara; Murphy, Aimee Luck; Skoble, Justin; Lemmens, Ed; Grous, John; Dubensky, Thomas Jr; Brockstedt, Dirk G; Jaffee, Elizabeth M

Redirecting apoptosis to aponecrosis induces selective cytotoxicity to pancreatic cancer cells through increased ROS, decline in ATP levels, and VDAC

将细胞凋亡重定向至细胞坏死可通过增加活性氧(ROS)、降低ATP水平和VDAC诱导对胰腺癌细胞的选择性细胞毒性。

Dinnen, Richard D; Mao, Yuehua; Qiu, Wanglong; Cassai, Nicholas; Slavkovich, Vesna N; Nichols, Gwen; Su, Gloria H; Brandt-Rauf, Paul; Fine, Robert L

Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.

癌症化学预防异硫氰酸酯对突变型 p53 的选择性消耗及其构效关系

Wang Xiantao, Di Pasqua Anthony J, Govind Sudha, McCracken Erin, Hong Charles, Mi Lixin, Mao Yuehua, Wu Jessie Yu-Chieh, Tomita York, Woodrick Jordan C, Fine Robert L, Chung Fung-Lung

First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas

卡培他滨联合替莫唑胺一线化疗治疗转移性胰腺内分泌癌

Strosberg, Jonathan R; Fine, Robert L; Choi, Junsung; Nasir, Aejaz; Coppola, Domenico; Chen, Dung-Tsa; Helm, James; Kvols, Larry

Intra-arterial mitoxantrone delivery in rabbits: an optical pharmacokinetic study

兔动脉内注射米托蒽醌:一项光学药代动力学研究

Joshi, Shailendra; Reif, Roberto; Wang, Mei; Zhang, Jane; Ergin, Aysegul; Bruce, Jeffery N; Fine, Robert L; Bigio, Irving J

Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor

替莫唑胺(Temodar®)和卡培他滨(Xeloda®)治疗侵袭性促肾上腺皮质激素垂体瘤

Thearle, Marie S; Freda, Pamela U; Bruce, Jeffrey N; Isaacson, Steven R; Lee, Yoomi; Fine, Robert L

Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer

胰腺蛋白酶疗法与吉西他滨化疗治疗胰腺癌的比较

Chabot, John A; Tsai, Wei-Yann; Fine, Robert L; Chen, Chunxia; Kumah, Carolyn K; Antman, Karen A; Grann, Victor R